Cargando…
Correction: Time to revisit the endpoint dilution assay and to replace the TCID(50) as a measure of a virus sample’s infection concentration
Autores principales: | Cresta, Daniel, Warren, Donald C., Quirouette, Christian, Smith, Amanda P., Lane, Lindey C., Smith, Amber M., Beauchemin, Catherine A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888671/ https://www.ncbi.nlm.nih.gov/pubmed/36719876 http://dx.doi.org/10.1371/journal.pcbi.1010877 |
Ejemplares similares
-
Time to revisit the endpoint dilution assay and to replace the TCID(50) as a measure of a virus sample’s infection concentration
por: Cresta, Daniel, et al.
Publicado: (2021) -
Monte Carlo simulation of the Spearman-Kaerber TCID50
por: Wulff, Niels H, et al.
Publicado: (2012) -
Automation of Infectious Focus Assay for Determination of Filovirus Titers and Direct Comparison to Plaque and TCID(50) Assays
por: Keiser, Patrick T., et al.
Publicado: (2021) -
Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6
por: Gustafsson, Rasmus K L, et al.
Publicado: (2012) -
Comparison among plaque assay, tissue culture infectious dose (TCID(50)) and real-time RT-PCR for SARS-CoV-2 variants quantification
por: Zapata-Cardona, Maria Isabel, et al.
Publicado: (2022)